165 results
Page 4 of 9
424B5
holqf qzp
10 Jun 20
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
27fl8pzyn9f
9 Jun 20
Fate Therapeutics Announces Proposed Public Offering of Common Stock
9:21pm
424B5
vu9dz n58vm
8 Jun 20
Prospectus supplement for primary offering
4:11pm
S-8
pki92urvu4z3
2 Mar 20
Registration of securities for employees
5:04pm
8-K
EX-99.1
apeq6odjc
2 Mar 20
Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook
4:01pm
8-K
EX-99.1
gogl ky97v17
5 Nov 19
Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
4:01pm
8-K
EX-1.1
sf1jz8xyoim7
12 Sep 19
Fate Therapeutics Announces Proposed Public Offering of Common Stock
9:30pm
424B5
4jl o6bz18s
12 Sep 19
Prospectus supplement for primary offering
9:25pm
424B5
noaptre
11 Sep 19
Prospectus supplement for primary offering
4:08pm